• 13989 Citations
  • 46 h-Index
1986 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 27 Similar Profiles
Stomach Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Stomach Medicine & Life Sciences
docetaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1986 2019

A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer

Bang, Y. J., Kang, Y. K., Ng, M., Chung, H., Wainberg, Z. A., Gendreau, S., Chan, W. Y., Xu, N., Maslyar, D., Meng, R., Chau, I. & Ajani, J. A., 2019 Feb 1, In : European Journal of Cancer. 108, p. 17-24 8 p.

Research output: Contribution to journalArticle

Esophagogastric Junction
Stomach
Disease-Free Survival
Placebos
Neoplasms

Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: Phase 1b results from the JAVELIN Solid Tumor trial

Chung, H., Arkenau, H. T., Lee, J., Rha, S., Oh, D. Y., Wyrwicz, L., Kang, Y. K., Lee, K. W., Infante, J. R., Lee, S. S., Kemeny, M., Keilholz, U., Melichar, B., Mita, A., Plummer, R., Smith, D., Gelb, A. B., Xiong, H., Hong, J., Chand, V. & 1 othersSafran, H., 2019 Feb 4, In : Journal for ImmunoTherapy of Cancer. 7, 1, 30.

Research output: Contribution to journalArticle

Esophagogastric Junction
Stomach
Maintenance
Disease-Free Survival
Neoplasms
1 Citation (Scopus)

Differences in the efficacies of pazopanib and gemcitabine/docetaxel as second-line treatments for metastatic soft tissue sarcoma

Kim, J. H., Park, H. S., Heo, S. J., Kim, S. K., Han, J. W., Shin, K. H., Kim, S. H., Hur, H., Kim, K. S., Choi, Y., Kim, S., Lee, Y. H., Suh, J., Ahn, J. B., Chung, H., Noh, S. H., Rha, S. & Kim, H. S., 2019 Feb 1, In : Oncology (Switzerland). 96, 2, p. 59-69 11 p.

Research output: Contribution to journalArticle

docetaxel
gemcitabine
Sarcoma
Therapeutics
Synovial Sarcoma

Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design

Moehler, M., Ryu, M. H., Dvorkin, M., Lee, K. W., Coşkun, H., Wong, R., Chung, H., Poltoratsky, A., Tsuji, A., Yen, C. J., Muntean, A. S., Le Sourd, S., Vaccaro, G. M., Overton, L., Boku, N., Wainberg, Z. A., Patel, M., Sharma, M., Xiong, H., Conti, I. & 2 othersTaieb, J. & Bang, Y. J., 2019 Feb 1, In : Future Oncology. 15, 6, p. 567-577 11 p.

Research output: Contribution to journalArticle

Stomach Neoplasms
Esophagogastric Junction
Stomach
oxaliplatin
Maintenance

Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer

Kim, C., Chon, H. J., Kim, J. H., Jung, M., Nam, C. M., Kim, H. S., Kang, B., Chung, H. & Rha, S., 2019 May 1, In : European Journal of Cancer. 112, p. 20-28 9 p.

Research output: Contribution to journalArticle

docetaxel
Fluorouracil
Stomach Neoplasms
Paclitaxel
Disease-Free Survival